{"prompt": "['Page 52 of 74', 'Protocol 036 (Nishijima, Kuppermann)', 'Time to', 'treatment (h) TXA vs. Placebo', 'Risk ratio (95% CI)', '1', '5.3 vs. 7.7%', '0.68 (0.57-0.82)', '1-3', '4.8 vs. 6.1%', '0.79 (0.64-0.97)', '>3', '4.4 vs. 3.1%', '1.44 (1.12-1.84)', 'All deaths', '4.9 vs. 5.7%', '0.85 (0.76-0.96)', '0.6', '0.8', '1', '1.2', '1.4', '1.6', 'Tranexamic acid better', 'Tranexamic acid worse', 'Figure 15: Mortality by time to treatment', '7.5 Potential Risks', 'A systematic review of children undergoing non-traumatic surgery suggests no increased', 'risk of complications following TXA treatment. 30 However, injured children were not', 'included in that systematic review and the authors acknowledge that none of the trials', 'included were powered to assess safety. 30 The CRASH-2 trial, a large trial of TXA in', 'injured adults, also suggested no increased complications in the TXA group. 19 Thus, we', 'do not anticipate an increased risk of complications in injured children receiving TXA', 'compared to placebo. The study, however, will monitor for specific potential risks as', 'described below.', 'The most important theoretical side effect of TXA is acute thrombosis, either arterial', 'or venous.', '78, 79 Acute thrombotic events are defined as vascular thrombosis resulting in', 'any of the following: cardiac ischemia, cerebral thrombosis, bowel infarction, deep venous', 'thrombosis, or pulmonary embolism. Seizures have been reported in cardiac surgery', 'patients receiving very high doses of TXA (61 to 259 mg/kg) with most receiving greater', 'than 100 mg/kg. 80-84 Although, the seizures were believed to be related to cerebral', 'ischemia associated with the cardiopulmonary bypass rather than TXA, 80 others have', 'suggested the seizures may be secondary to TXA inhibition of gamma-aminobutyric acid', 'receptors in neurons. 81 Furthermore, the reported doses of TXA are substantially higher', 'than planned in this study. In addition, seizures are a complication of severe trauma,', 'especially in patients with traumatic brain injuries and those with episodes of hypoxia.', 'Thus, we will evaluate for these potential complications but do not anticipate that seizure', 'events are secondary to the doses of TXA planned for use in this study. Lastly, cerebral', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']['Protocol 036 (Nishijima, Kuppermann)', 'Page 53 of 74', 'Proportion of patients that will benefit from treatment', '80', '70', '60', 'Effect of delay', '50', '40', '30', '20', '10', '0', 'Risk of death', '9', '8', '7', '6', 'Effect of delay', '5', '4', 'No intervention', '3', 'Intervention not delayed', 'Intervention delayed by 1 h', '0', '0', '1', '2', '3', '4', '5', 'Hours from injury to arrival at hospital', 'Figure 16: Effect of 1 hour delay in start of treatment with TXA on proportion of patients', 'who will benefit and on risk of death', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']\n\n###\n\n", "completion": "END"}